I-MED Radiology, Wesley Hospital
Brisbane, Australia
We welcome I-MED Radiology at The Wesley Hospital to the IASIOS community as an Accredited Centre.
IASIOS Council
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy

We are delighted to announce that the University Hospital of Pisa in Italy has been awarded IASIOS Accredited Centre status. This achievement recognises that its interventional oncology service fulfils internationally established standards for quality assurance, patient safety, and multidisciplinary cancer care.
IASIOS accreditation reflects a clear commitment to structured clinical pathways, evidence-based treatment, and the ongoing evolution of interventional oncology practice. It also highlights the increasing role of image-guided, minimally invasive therapies in delivering effective and patient-focused cancer care.
Congratulations to Prof. Laura Crocetti and the entire team on this accomplishment, which represents an important contribution to advancing interventional oncology standards.
Anadolu Medical Center
Gebze/Kocaeli, Turkey
We are pleased to announce that Anadolu Medical Center has earned designation as an IASIOS Accredited Centre. This distinction recognises the strength of its interventional oncology service, led by Dr. Murat Dökdök, and its alignment with demanding international standards in patient care, safety, and coordinated cancer management.
This accreditation reflects a strong commitment to evidence-based practice, effective clinical oversight, and continuous advancement in the field. It also highlights the growing role of image-guided, minimally invasive therapies in shaping contemporary cancer treatment.
Congratulations to Dr. Dökdök and the entire team for this significant milestone, underscoring their contribution to advancing interventional oncology at an international level.
IASIOS Council
Guys and St. Thomas’ NHS Foundation Trust
London, UK

We are pleased to recognise that Guy’s and St Thomas’ NHS Foundation Trust has achieved accreditation as an IASIOS Accredited Centre. This reflects the service’s commitment to high-quality, patient-centred, image-guided cancer care delivered within a strong framework of clinical governance and multidisciplinary collaboration.
The facility, with Dr. Shahzad Ilyas, has demonstrated excellence in advancing minimally invasive oncologic treatments, supported by a dedicated team focused on safety, innovation, and continuous improvement. We also acknowledge the valuable guidance of Prof. Andrew Adam as part of our Steering Board, contributing to the strategic development and strength of the service.
Congratulations to the entire team on this important milestone in interventional oncology excellence.
IASIOS Council
